TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotechst Lund AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
63
|
55
|
75 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
1
|
-9
|
7 |
| EBITDA |
1
|
-9
|
7 |
| Total assets |
30
|
29
|
47 |
| Current assets |
30
|
29
|
47 |
| Current liabilities |
8
|
9
|
16 |
| Equity capital |
22
|
20
|
31 |
| - share capital |
9
|
8
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
73.3%
|
69.0%
|
66.0% |
| Turnover per employee |
63
|
55
|
75 |
| Profit as a percentage of turnover |
1.6%
|
-16.4%
|
9.3% |
| Return on assets (ROA) |
3.3%
|
-31.0%
|
14.9% |
| Current ratio |
375.0%
|
322.2%
|
293.8% |
| Return on equity (ROE) |
4.5%
|
-45.0%
|
22.6% |
| Change turnover |
6
|
-13
|
10 |
| Change turnover % |
10%
|
-19%
|
15% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.